Open Monoclonal Technology Announces OmniRat™ Collaboration With CNA Development LLC, an Affiliate of Janssen Pharmaceuticals, Inc.

PALO ALTO, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT) today announced a discovery collaboration with CNA Development LLC, an affiliate of Janssen Pharmaceuticals, Inc.

MORE ON THIS TOPIC